Skip to main content
Skip to main content
Go to homepage

Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy in US Patients With Cystic Fibrosis

Incidence of and Risk Factors for Fibrosing Colonopathy in Patients With Cystic Fibrosis

Description:

For complete information, please view the study on clinicaltrials.gov

Study Status:
Closed
Full IRB Study Title:
A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy in US Patients With Cystic Fibrosis Treated With Pancreatic Enzyme Replacement Therapy: A Harmonized Protocol Across Sponsors
IRB Study ID:
996785-2
If you are interested in this study or have questions about your child's eligibility, please contact:
Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org
Lead Investigator
Gregory Omlor, MD, FAAP

Director, Lewis H Walker CF Center; Pediatric Pulmonologist; Pediatric Sleep Medicine
Lewis H. Walker, MD, Cystic Fibrosis CenterRobert T. Stone, MD, Respiratory CenterPediatric Sleep Medicine

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.